Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

BLISS GVS PHARMA LTD. - 506197 - Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2022

 We would like to inform you that, Board Meeting of the Company was held today i.e. Monday, November 07, 2022 at the registered office of the Company. In pursuant to Regulation 30 and 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 the Board has considered and approved the following matter amongst others: 1. The Unaudited Standalone and Consolidated Financial Results of the company for the quarter and half year ended September 30, 2022. A copy of unaudited financial results along with the Limited Review Report of the Auditors of the Company are enclosed herewith as 'Annexure - I'. The meeting of the Board of Directors commenced at 05:30 p.m. and concluded at 07:45 p.m.
07-11-2022
Bigul

BLISS GVS PHARMA LTD. - 506197 - Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year September 30, 2022

 BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2022 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year September 30, 2022. Further, pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons, the trading window for dealing in shares of the Company was closed for all the Designated Persons of the Company and their immediate relatives of the Company from October 01, 2022 and shall remain closed until 48 hours after the announcement of unaudited Financial Results of the Company for the quarter and half year September 30, 2022.
29-10-2022
Bigul

BLISS GVS PHARMA LTD. - 506197 - Disclosure Regarding The Inclusion Of Names In The Category Of Promoter/Promoter Group Of The Company.

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform your good office regarding the inclusion of new names in the Category of Promoter/Promoter Group of the Company.
21-10-2022
Bigul

BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer Agent of Company M/s. Universal Capital Securities Private Limited has intimated regarding issue of duplicate share certificates to the shareholder of the Company.
21-10-2022
Bigul

BLISS GVS PHARMA LTD. - 506197 - Statement Of Investor Complaints For The Quarter Ended September 2022

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 2790 Name of the Signatory :- Aditi BhattDesignation :- Company Secretary and Compliance Officer
20-10-2022
Bigul

BLISS GVS PHARMA LTD. - 506197 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Please find enclosed herewith a certificate received from Universal Capital Securities Private Limited, Registrar and Share Transfer Agent of the Company under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2022
10-10-2022
Bigul

BLISS GVS PHARMA LTD. - 506197 - Closure of Trading Window

 This is to inform you that pursuant to Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (including any statutory modification(s) or re-enactment(s) thereof, for the time being in force) and in accordance with the Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons, the Trading window for dealing in securities/shares of Bliss GVS Pharma Limited ('the Company') will remain closed for Insiders, Designated Persons and their immediate relatives of the Company with effect from Saturday, October 01, 2022 until 48 hours after the announcement of the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2022
30-09-2022
Bigul

BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer Agent of Company M/s. Universal Capital Securities Private Limited has received request for issue of duplicate share certificates consequent to loss of share certificates from the shareholder.
30-09-2022
Bigul

BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer Agent of Company M/s. Universal Capital Securities Private Limited has received request for issue of duplicate share certificates consequent to loss of share certificates from the following shareholder
26-09-2022
Bigul

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

 We would like to inform you that, the ESOP Allotment Committee of the Company at its meeting held on September 15, 2022 has approved the allotment of 76,750 equity shares of face value of Re. 1/- each to the eligible employees who have exercised their stock options under Bliss GVS Pharma Limited-Employee Stock Option Plan 2019 ('Bliss GVS ESOP-2019').
15-09-2022
Next Page
Close

Let's Open Free Demat Account